[go: up one dir, main page]

DD298089A5 - Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe - Google Patents

Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe Download PDF

Info

Publication number
DD298089A5
DD298089A5 DD90343516A DD34351690A DD298089A5 DD 298089 A5 DD298089 A5 DD 298089A5 DD 90343516 A DD90343516 A DD 90343516A DD 34351690 A DD34351690 A DD 34351690A DD 298089 A5 DD298089 A5 DD 298089A5
Authority
DD
German Democratic Republic
Prior art keywords
carbon atoms
chain
straight
branched alkyl
optionally substituted
Prior art date
Application number
DD90343516A
Other languages
German (de)
English (en)
Inventor
Klaus Mohrs
Siegfried Raddatz
Romanis Fruchtmann
Christian Kohlsdorfer
Reiner Mueller-Peddinghaus
Pia Theisen-Popp
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD298089A5 publication Critical patent/DD298089A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD90343516A 1989-08-19 1990-08-17 Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe DD298089A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927369A DE3927369A1 (de) 1989-08-19 1989-08-19 Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe

Publications (1)

Publication Number Publication Date
DD298089A5 true DD298089A5 (de) 1992-02-06

Family

ID=6387408

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343516A DD298089A5 (de) 1989-08-19 1990-08-17 Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe

Country Status (18)

Country Link
US (1) US5179106A (hu)
EP (1) EP0414019B1 (hu)
JP (1) JPH0390062A (hu)
KR (1) KR910004568A (hu)
CN (2) CN1049656A (hu)
AT (1) ATE138651T1 (hu)
AU (1) AU632846B2 (hu)
CA (1) CA2023517A1 (hu)
DD (1) DD298089A5 (hu)
DE (2) DE3927369A1 (hu)
DK (1) DK0414019T3 (hu)
FI (1) FI904058A0 (hu)
HU (1) HU208813B (hu)
IE (1) IE902987A1 (hu)
IL (1) IL95391A (hu)
NZ (1) NZ234931A (hu)
PT (1) PT95024A (hu)
ZA (1) ZA906531B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
DE4139750A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
CA2092152A1 (en) * 1992-03-23 1993-09-24 Azuma Igarashi Phenoxyacetic acid compounds and medical preparations containing them
DE4226519A1 (de) * 1992-08-11 1994-02-17 Bayer Ag 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
US5612377A (en) * 1994-08-04 1997-03-18 Minnesota Mining And Manufacturing Company Method of inhibiting leukotriene biosynthesis
DE59607066D1 (de) 1995-07-12 2001-07-19 Bayer Ag Verfahren zur Herstellung von Cyclopentylbromid
ATE242208T1 (de) * 1997-01-29 2003-06-15 Pfizer Sulfonylharnstoff-derivate und ihre verwendung in der kontrolle der interleukin-1-aktivität
CN1295215C (zh) * 2002-12-31 2007-01-17 中国医学科学院药物研究所 黄皮酰胺的光学活性衍生物、其制法和其药物组合物与用途
AR047329A1 (es) 2003-12-12 2006-01-18 Wyeth Corp Derivados de quinolinas para el tratamiento de enfermedades cardiovasculares. composiciones farmaceuticas
CN102101850B (zh) * 2011-03-10 2013-06-12 广州诺浩医药科技有限公司 Swern氧化法制备黄皮酰胺中间体
CN102249976B (zh) 2011-06-10 2012-11-14 中国科学院化学研究所 一种光学纯的（-）-黄皮酰胺类化合物的制备方法
WO2016015333A1 (en) * 2014-08-01 2016-02-04 F.Hoffmann-La Roche Ag 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2948472A1 (de) * 1979-12-01 1981-06-11 Hoechst Ag, 6000 Frankfurt Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
US4876346A (en) * 1985-05-02 1989-10-24 American Home Products Corporation Quinoline compounds
GB2185741B (en) * 1986-01-27 1989-10-25 American Home Prod Heterocyclic sulphonamides
DE3632329A1 (de) * 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
WO1988006886A1 (en) * 1987-03-18 1988-09-22 American Home Products Corporation Sulfonylcarboxamides
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
AU617386B2 (en) * 1987-12-01 1991-11-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Substituted quinolines

Also Published As

Publication number Publication date
AU632846B2 (en) 1993-01-14
CN1040440C (zh) 1998-10-28
HU905055D0 (en) 1991-01-28
IL95391A (en) 1994-05-30
CN1049656A (zh) 1991-03-06
EP0414019A3 (en) 1992-05-13
AU6114090A (en) 1991-02-21
EP0414019A2 (de) 1991-02-27
HU208813B (en) 1994-01-28
PT95024A (pt) 1991-05-22
DE59010347D1 (de) 1996-07-04
IL95391A0 (en) 1991-06-30
ATE138651T1 (de) 1996-06-15
CN1050022A (zh) 1991-03-20
HUT54988A (en) 1991-04-29
US5179106A (en) 1993-01-12
NZ234931A (en) 1992-07-28
DK0414019T3 (da) 1996-10-07
CA2023517A1 (en) 1991-02-20
IE902987A1 (en) 1991-02-27
JPH0390062A (ja) 1991-04-16
EP0414019B1 (de) 1996-05-29
KR910004568A (ko) 1991-03-28
ZA906531B (en) 1991-06-26
DE3927369A1 (de) 1991-02-21
FI904058A0 (fi) 1990-08-16

Similar Documents

Publication Publication Date Title
EP0339416B1 (de) Gegebenenfalls alpha-substituierte 4-(Chinolin-2-yl-methoxy)phenylessigsäuren und -ester
EP0399291B1 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0414019B1 (de) Substituierte N-(Chinolin-2-yl-methoxy)benzylsulfonylharnstoffe
EP0414078B1 (de) Disubstituierte (Chinolin-2-yl-methoxy) phenylessigsäure-Derivate
EP0414076B1 (de) Cyclisch substituierte (Chinolin-2-yl-methoxy)phenyl-essigsäure-Derivate
EP0499926B1 (de) 2-Substituierte Chinoline, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE3305569A1 (de) Biscarboxamide zur bekaempfung von erkrankungen sowie verfahren zu ihrer herstellung
DD235256A5 (de) Verfahren zur herstellung neuer substituierter pyrrolidinone
DD296913A5 (de) Substituierte (chinolin-2-yl-methoxy)phenyl-n,n'-sulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0529450B1 (de) Substituierte Mandelsäurederivate, als 5-Lipoxygenasehemmer
DE4139751A1 (de) Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
EP0582908B1 (de) 2-Substituierte Chinolylmethoxy-phenylessigsäure- und -benzylacyl Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Leukotriensynthese Hemmer
EP0530639A1 (de) Heterocyclisch substituierte Chinolylmethoxy-Phenylacetamide als Lipoxygenasehemmer
EP0428860B1 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-carbonyl-harnstoffe
DD259401A5 (de) Verfahren zur herstellung von 2-alkylbenzimidazol-derivaten
DE4219765A1 (de) Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
EP0519291A1 (de) Aminomethyl-substituierte 2,3-Dihydropyrano(2,3-b)pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4125270A1 (de) Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
EP0424722B1 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-thioharnstoffe
DE4139749A1 (de) Chinolylmethoxyphenyl-essigsaeureamide
DD234005A5 (de) Verfahren zur herstellung neuer 1,2,4-triazacycloalkadienderivate
EP0582916A1 (de) N-Methansulfonyl-2- 3-isobutyl-3-(chinolin-2-yl-methoxy)phenyl -2-cycloalkylessigsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4139750A1 (de) Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
LU80422A1 (de) Verfahren zur herstellung von pharmazeutischen praeparaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee